Heron Therapeutics (HRTX) Interest & Investment Income (2016 - 2026)
Heron Therapeutics' (HRTX) quarterly Interest & Investment Income came in at -$10000.0 in Q1 2026, up 16.67% YoY from -$8571.4 in Q1 2025, and down 100.51% on a QoQ basis from $2.0 million in Q4 2025.
Heron Therapeutics (HRTX) Interest & Investment Income (2016 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 11 years of Interest & Investment Income data on file, last reported at -$10000.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 16.67% year-over-year to -$10000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 45.18% YoY) and the FY2025 annual result came in at $1.9 million, down 45.13% from the prior year.
- Interest & Investment Income eased to -$10000.0 in Q1 2026, from $2.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $3.5 million in Q4 2024 to a low of -$46000.0 in Q3 2022.
- A 5-year average of $323941.2 and a median of -$2000.0 in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income tumbled 400.0% — and 2024, when it soared 25064.29%.
- Tracing HRTX's Interest & Investment Income over 5 years: stood at $38000.0 in 2022, then sank by 63.16% to $14000.0 in 2023, then soared by 25064.29% to $3.5 million in 2024, then sank by 44.34% to $2.0 million in 2025, then tumbled by 100.51% to -$10000.0 in 2026.
- The last three Interest & Investment Income figures came in at -$10000.0 (Q1 2026), $2.0 million (Q4 2025), and $1000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Heron Therapeutics | 59.96 Mn | 17.29 Mn | 26.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | 1.96 Mn |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | -12,000.00 |
| Dec 31, 2024 | 3.52 Mn |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -19,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | -15,000.00 |
| Mar 31, 2023 | 28,000.00 |
| Dec 31, 2022 | 38,000.00 |
| Sep 30, 2022 | -46,000.00 |
| Jun 30, 2022 | -3,000.00 |
| Mar 31, 2022 | -2,000.00 |
| Dec 31, 2021 | 694,000.00 |
| Sep 30, 2021 | -45,000.00 |
| Jun 30, 2021 | -80,000.00 |